{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:07:53Z","timestamp":1791284873252,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013153","name":"Shantou Science and Technology Project","doi-asserted-by":"publisher","award":["240428226498013"],"award-info":[{"award-number":["240428226498013"]}],"id":[{"id":"10.13039\/501100013153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["213769"],"award-info":[{"award-number":["213769"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108016"],"award-info":[{"award-number":["82020108016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071973"],"award-info":[{"award-number":["82071973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010326"],"award-info":[{"award-number":["2023A1515010326"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Platform and Project of Guangdong University","award":["2022ZDZX2020"],"award-info":[{"award-number":["2022ZDZX2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01672-3","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T08:22:49Z","timestamp":1736756569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer\u2019s disease mice"],"prefix":"10.1186","volume":"17","author":[{"given":"Yuanyu","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"1672_CR1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u2009\u2013\u2009821.","DOI":"10.1002\/alz.13809"},{"key":"1672_CR2","doi-asserted-by":"crossref","unstructured":"Nichols E, Vos TJAs D. The estimation of the global prevalence of dementia from 1990-2019 and forecasted prevalence through 2050: an analysis for the global burden of Disease (GBD) study 2019. 2021;17:e051496.","DOI":"10.1002\/alz.051496"},{"issue":"2","key":"1672_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. Alzheimer\u2019s Disease: Epidemiology and Clinical Progression. Neurol Ther. 2022;11(2):553\u201369.","journal-title":"Neurol Ther"},{"issue":"2","key":"1672_CR4","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"Estimation of the global prevalence of dementia","year":"2022","unstructured":"Estimation of the global prevalence of dementia. In 2019 and forecasted prevalence in 2050: an analysis for the global burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"key":"1672_CR5","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.eclinm.2022.101580","volume":"51","author":"A Nandi","year":"2022","unstructured":"Nandi A, Counts N, Chen S, Seligman B, Tortorice D, Vigo D, et al. Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: a value of statistical life approach. EClinicalMedicine. 2022;51:101580.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"1672_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer Disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell"},{"issue":"1","key":"1672_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Translational Neurodegeneration. 2021;10(1):45.","journal-title":"Translational Neurodegeneration"},{"issue":"12","key":"1672_CR8","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1038\/s41380-023-02140-w","volume":"28","author":"G Carello-Collar","year":"2023","unstructured":"Carello-Collar G, Bellaver B, Ferreira PCL, Ferrari-Souza JP, Ramos VG, Therriault J, et al. The GABAergic system in Alzheimer\u2019s disease: a systematic review with meta-analysis. Mol Psychiatry. 2023;28(12):5025\u201336.","journal-title":"Mol Psychiatry"},{"key":"1672_CR9","doi-asserted-by":"crossref","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A et al. Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations. Int J Mol Sci. 2022;23(22).","DOI":"10.3390\/ijms232213954"},{"key":"1672_CR10","doi-asserted-by":"crossref","unstructured":"Reardon S. Alzheimer\u2019s drug with modest benefits wins backing of FDA advisers. Nature. 2024.","DOI":"10.1038\/d41586-024-01726-w"},{"key":"1672_CR11","doi-asserted-by":"crossref","unstructured":"Yu TW, Lane HY, Lin CH. Novel Therapeutic Approaches for Alzheimer\u2019s Disease: An Updated Review. Int J Mol Sci. 2021;22(15).","DOI":"10.3390\/ijms22158208"},{"issue":"12","key":"1672_CR12","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1093\/brain\/awab222","volume":"144","author":"DC Matthews","year":"2021","unstructured":"Matthews DC, Mao X, Dowd K, Tsakanikas D, Jiang CS, Meuser C, et al. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer\u2019s disease. Brain. 2021;144(12):3742\u201355.","journal-title":"Brain"},{"issue":"2","key":"1672_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.13230","volume":"135","author":"HC Hunsberger","year":"2015","unstructured":"Hunsberger HC, Weitzner DS, Rudy CC, Hickman JE, Libell EM, Speer RR, et al. Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression. J Neurochem. 2015;135(2):381\u201394.","journal-title":"J Neurochem"},{"issue":"4","key":"1672_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jnc.15224","volume":"156","author":"KN Hascup","year":"2021","unstructured":"Hascup KN, Findley CA, Britz J, Esperant-Hilaire N, Broderick SO, Delfino K, et al. Riluzole attenuates glutamatergic tone and cognitive decline in A\u03b2PP\/PS1 mice. J Neurochem. 2021;156(4):513\u201323.","journal-title":"J Neurochem"},{"key":"1672_CR15","doi-asserted-by":"crossref","unstructured":"Pfitzer J, Pinky PD, Perman S, Redmon E, Cmelak L, Suppiramaniam V et al. Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and synaptic and memory impairments in 3xTg-AD mice. J Neurochem. 2024.","DOI":"10.1101\/2024.06.11.598453"},{"key":"1672_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2022.04.051","volume":"610","author":"K Saba","year":"2022","unstructured":"Saba K, Patel AB. Riluzole restores memory and brain energy metabolism in A\u03b2PP-PS1 mouse model of Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2022;610:140\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1672_CR17","doi-asserted-by":"publisher","first-page":"110077","DOI":"10.1016\/j.pnpbp.2020.110077","volume":"108","author":"Y Yang","year":"2021","unstructured":"Yang Y, Ji WG, Zhang YJ, Zhou LP, Chen H, Yang N, et al. Riluzole ameliorates soluble A\u03b2(1\u201342)-induced impairments in spatial memory by modulating the glutamatergic\/GABAergic balance in the dentate gyrus. Prog Neuro-psychopharmacol Biol Psychiatry. 2021;108:110077.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"1672_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biopha.2016.12.067","volume":"87","author":"Z Mokhtari","year":"2017","unstructured":"Mokhtari Z, Baluchnejadmojarad T, Nikbakht F, Mansouri M, Roghani M. Riluzole ameliorates learning and memory deficits in A\u03b225-35-induced rat model of Alzheimer\u2019s disease and is independent of cholinoceptor activation. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2017;87:135\u201344.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"1","key":"1672_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41398-018-0201-z","volume":"8","author":"M Okamoto","year":"2018","unstructured":"Okamoto M, Gray JD, Larson CS, Kazim SF, Soya H, McEwen BS, et al. Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer\u2019s disease. Translational Psychiatry. 2018;8(1):153.","journal-title":"Translational Psychiatry"},{"key":"1672_CR20","doi-asserted-by":"publisher","first-page":"101503","DOI":"10.1016\/j.arr.2021.101503","volume":"72","author":"T Song","year":"2021","unstructured":"Song T, Song X, Zhu C, Patrick R, Skurla M, Santangelo I, et al. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev. 2021;72:101503.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"1672_CR21","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00330-016-4669-8","volume":"27","author":"D Huang","year":"2017","unstructured":"Huang D, Liu D, Yin J, Qian T, Shrestha S, Ni H. Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment. Eur Radiol. 2017;27(7):2698\u2013705.","journal-title":"Eur Radiol"},{"issue":"5","key":"1672_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jalz.2013.08.282","volume":"10","author":"AC Londono","year":"2014","unstructured":"Londono AC, Castellanos FX, Arbelaez A, Ruiz A, Aguirre-Acevedo DC, Richardson AM, et al. An 1H-MRS framework predicts the onset of Alzheimer\u2019s disease symptoms in PSEN1 mutation carriers. Alzheimers Dement. 2014;10(5):552\u201361.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1672_CR23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3233\/JAD-190773","volume":"73","author":"D Wong","year":"2020","unstructured":"Wong D, Atiya S, Fogarty J, Montero-Odasso M, Pasternak SH, Brymer C, et al. Reduced hippocampal glutamate and posterior cingulate N-Acetyl aspartate in mild cognitive impairment and Alzheimer\u2019s disease is Associated with episodic memory performance and White Matter Integrity in the Cingulum: a pilot study. J Alzheimer\u2019s Disease: JAD. 2020;73(4):1385\u2013405.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"issue":"3","key":"1672_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/hipo.22693","volume":"27","author":"R Crescenzi","year":"2017","unstructured":"Crescenzi R, DeBrosse C, Nanga RP, Byrne MD, Krishnamoorthy G, D\u2019Aquilla K, et al. Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice. Hippocampus. 2017;27(3):285\u2013302.","journal-title":"Hippocampus"},{"key":"1672_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neuroimage.2014.06.067","volume":"101","author":"R Crescenzi","year":"2014","unstructured":"Crescenzi R, DeBrosse C, Nanga RP, Reddy S, Haris M, Hariharan H, et al. In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy. NeuroImage. 2014;101:185\u201392.","journal-title":"NeuroImage"},{"key":"1672_CR26","doi-asserted-by":"crossref","unstructured":"Igarashi H, Ueki S, Kitaura H, Kera T, Ohno K, Ohkubo M et al. Longitudinal GluCEST MRI Changes and Cerebral Blood Flow in 5xFAD Mice. Contrast media & molecular imaging. 2020;2020:8831936.","DOI":"10.1155\/2020\/8831936"},{"key":"1672_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2019.04.010","volume":"1717","author":"DH Lee","year":"2019","unstructured":"Lee DH, Lee DW, Kwon JI, Kim ST, Woo CW, Kon Kim J, et al. Changes to gamma-aminobutyric acid levels during short-term epileptiform activity in a kainic acid-induced rat model of status epilepticus: a chemical exchange saturation transfer imaging study. Brain Res. 2019;1717:176\u201381.","journal-title":"Brain Res"},{"issue":"14","key":"1672_CR28","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.18632\/aging.102095","volume":"11","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zong X, Huang J, Guan Y, Li Y, Du T, et al. Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice. Aging. 2019;11(14):5008\u201334.","journal-title":"Aging"},{"key":"1672_CR29","doi-asserted-by":"crossref","unstructured":"Orzy\u0142owska A, Oakden W. Saturation Transfer MRI for Detection of Metabolic and Microstructural Impairments Underlying Neurodegeneration in Alzheimer\u2019s Disease. Brain Sci. 2021;12(1).","DOI":"10.3390\/brainsci12010053"},{"issue":"10","key":"1672_CR30","doi-asserted-by":"publisher","first-page":"e0163765","DOI":"10.1371\/journal.pone.0163765","volume":"11","author":"G Yan","year":"2016","unstructured":"Yan G, Zhang T, Dai Z, Yi M, Jia Y, Nie T, et al. A potential magnetic resonance imaging technique based on Chemical Exchange Saturation transfer for in vivo \u03b3-Aminobutyric acid imaging. PLoS ONE. 2016;11(10):e0163765.","journal-title":"PLoS ONE"},{"issue":"6","key":"1672_CR31","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/mrm.21873","volume":"61","author":"M Kim","year":"2009","unstructured":"Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med. 2009;61(6):1441\u201350.","journal-title":"Magn Reson Med"},{"issue":"2","key":"1672_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nm.2615","volume":"18","author":"K Cai","year":"2012","unstructured":"Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, et al. Magnetic resonance imaging of glutamate. Nat Med. 2012;18(2):302\u20136.","journal-title":"Nat Med"},{"issue":"4","key":"1672_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/nbm.2875","volume":"26","author":"M Haris","year":"2013","unstructured":"Haris M, Nath K, Cai K, Singh A, Crescenzi R, Kogan F, et al. Imaging of glutamate neurotransmitter alterations in Alzheimer\u2019s disease. NMR Biomed. 2013;26(4):386\u201391.","journal-title":"NMR Biomed"},{"key":"1672_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2018.09.027","volume":"73","author":"G Oeltzschner","year":"2019","unstructured":"Oeltzschner G, Wijtenburg SA, Mikkelsen M, Edden RAE, Barker PB, Joo JH, et al. Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla. Neurobiol Aging. 2019;73:211\u20138.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1672_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2009.05.002","volume":"32","author":"R Rupsingh","year":"2011","unstructured":"Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging. 2011;32(5):802\u201310.","journal-title":"Neurobiol Aging"},{"key":"1672_CR36","doi-asserted-by":"publisher","first-page":"890855","DOI":"10.3389\/fnagi.2022.890855","volume":"14","author":"F Bellanti","year":"2022","unstructured":"Bellanti F, Bukke VN, Moola A, Villani R, Scuderi C, Steardo L, et al. Effects of Ultramicronized Palmitoylethanolamide on mitochondrial bioenergetics, cerebral metabolism, and glutamatergic transmission: an Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer\u2019s Disease. Front Aging Neurosci. 2022;14:890855.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"1672_CR37","doi-asserted-by":"publisher","first-page":"e13005","DOI":"10.1111\/bpa.13005","volume":"31","author":"JHY Yeung","year":"2021","unstructured":"Yeung JHY, Walby JL, Palpagama TH, Turner C, Waldvogel HJ, Faull RLM, et al. Glutamatergic receptor expression changes in the Alzheimer\u2019s disease hippocampus and entorhinal cortex. Brain Pathol. 2021;31(6):e13005.","journal-title":"Brain Pathol"},{"key":"1672_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroimage.2012.12.004","volume":"86","author":"PG Mullins","year":"2014","unstructured":"Mullins PG, McGonigle DJ, O\u2019Gorman RL, Puts NA, Vidyasagar R, Evans CJ, et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. NeuroImage. 2014;86:43\u201352.","journal-title":"NeuroImage"},{"key":"1672_CR39","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.pneurobio.2022.102331","volume":"217","author":"JV Andersen","year":"2022","unstructured":"Andersen JV, Schousboe A, Verkhratsky A. Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: integration of the glutamate\/GABA-glutamine cycle. Prog Neurobiol. 2022;217:102331.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"1672_CR40","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3233\/JAD-215431","volume":"87","author":"A Hone-Blanchet","year":"2022","unstructured":"Hone-Blanchet A, Bohsali A, Krishnamurthy LC, Shahid SS, Lin Q, Zhao L, et al. Frontal metabolites and Alzheimer\u2019s disease biomarkers in healthy older women and women diagnosed with mild cognitive impairment. J Alzheimer\u2019s Disease: JAD. 2022;87(3):1131\u201341.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"issue":"1","key":"1672_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2014.07.030","volume":"36","author":"F Riese","year":"2015","unstructured":"Riese F, Gietl A, Z\u00f6lch N, Henning A, O\u2019Gorman R, K\u00e4lin AM, et al. Posterior cingulate \u03b3-aminobutyric acid and glutamate\/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype. Neurobiol Aging. 2015;36(1):53\u20139.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1672_CR42","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/jmri.24665","volume":"41","author":"X Bai","year":"2015","unstructured":"Bai X, Edden RA, Gao F, Wang G, Wu L, Zhao B, et al. Decreased \u03b3-aminobutyric acid levels in the parietal region of patients with Alzheimer\u2019s disease. J Magn Reson Imaging: JMRI. 2015;41(5):1326\u201331.","journal-title":"J Magn Reson Imaging: JMRI"},{"key":"1672_CR43","doi-asserted-by":"publisher","first-page":"105198","DOI":"10.1016\/j.nbd.2020.105198","volume":"148","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Christensen SK, Westi EW, Diaz-delCastillo M, Tanila H, Schousboe A, et al. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2021;148:105198.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1672_CR44","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1134\/S0006297923120027","volume":"88","author":"AO Burnyasheva","year":"2023","unstructured":"Burnyasheva AO, Stefanova NA, Kolosova NG, Telegina DV. Changes in the Glutamate\/GABA system in the Hippocampus of rats with age and during Alzheimer\u2019s Disease signs Development. Biochem Biokhimiia. 2023;88(12):1972\u201386.","journal-title":"Biochem Biokhimiia"},{"issue":"3","key":"1672_CR45","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.18632\/aging.102830","volume":"12","author":"A Vall\u00e9e","year":"2020","unstructured":"Vall\u00e9e A, Vall\u00e9e JN, Guillevin R, Lecarpentier Y. Riluzole: a therapeutic strategy in Alzheimer\u2019s disease by targeting the WNT\/\u03b2-catenin pathway. Aging. 2020;12(3):3095\u2013113.","journal-title":"Aging"},{"issue":"2","key":"1672_CR46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/mp.2016.33","volume":"22","author":"AC Pereira","year":"2017","unstructured":"Pereira AC, Gray JD, Kogan JF, Davidson RL, Rubin TG, Okamoto M, et al. Age and Alzheimer\u2019s disease gene expression profiles reversed by the glutamate modulator riluzole. Mol Psychiatry. 2017;22(2):296\u2013305.","journal-title":"Mol Psychiatry"},{"key":"1672_CR47","doi-asserted-by":"publisher","first-page":"104808","DOI":"10.1016\/j.neuint.2020.104808","volume":"139","author":"T Tanaka","year":"2020","unstructured":"Tanaka T, Ohashi S, Takashima A, Kobayashi S. Glutamate-responsive translation of dendritic GSK3\u03b2 mRNA triggers a cycle for amplification of reactivated preexisting GSK3\u03b2 that is indispensable for tau hyperphosphorylation. Neurochem Int. 2020;139:104808.","journal-title":"Neurochem Int"},{"issue":"6453","key":"1672_CR48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer HJ, Frosch MP, et al. A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation. Sci (New York NY). 2019;365(6453):559\u201365.","journal-title":"Sci (New York NY)"},{"issue":"5","key":"1672_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/mp.2008.106","volume":"15","author":"M Banasr","year":"2010","unstructured":"Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, et al. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry. 2010;15(5):501\u201311.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"1672_CR50","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcp.22609","volume":"226","author":"K Kim","year":"2011","unstructured":"Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol. 2011;226(10):2484\u201393.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1672_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.410400512","volume":"40","author":"E Masliah","year":"1996","unstructured":"Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease. Ann Neurol. 1996;40(5):759\u201366.","journal-title":"Ann Neurol"},{"issue":"1\u20133","key":"1672_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuint.2009.01.020","volume":"55","author":"C Buddhala","year":"2009","unstructured":"Buddhala C, Hsu CC, Wu JY. A novel mechanism for GABA synthesis and packaging into synaptic vesicles. Neurochem Int. 2009;55(1\u20133):9\u201312.","journal-title":"Neurochem Int"},{"issue":"4","key":"1672_CR53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-2012-121330","volume":"33","author":"C Schwab","year":"2013","unstructured":"Schwab C, Yu S, Wong W, McGeer EG, McGeer PL. GAD65, GAD67, and GABAT immunostaining in human brain and apparent GAD65 loss in Alzheimer\u2019s disease. J Alzheimer\u2019s Disease: JAD. 2013;33(4):1073\u201388.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"1672_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1326-6-55","volume":"6","author":"M Olabarria","year":"2011","unstructured":"Olabarria M, Noristani HN, Verkhratsky A, Rodr\u00edguez JJ. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer\u2019s disease mouse model: mechanism for deficient glutamatergic transmission? Mol Neurodegeneration. 2011;6:55.","journal-title":"Mol Neurodegeneration"},{"issue":"6","key":"1672_CR55","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1042\/BST20130237","volume":"41","author":"CF Rose","year":"2013","unstructured":"Rose CF, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans. 2013;41(6):1518\u201324.","journal-title":"Biochem Soc Trans"},{"key":"1672_CR56","doi-asserted-by":"crossref","unstructured":"Maguin C, Mougel E, Valette J, Flament J. Toward quantitative CEST imaging of glutamate in the mouse brain using a multi-pool exchange model calibrated by (1)H-MRS. Magnetic resonance in medicine. 2024.","DOI":"10.1002\/mrm.30353"},{"key":"1672_CR57","unstructured":"Severo F. Shemesh NJapa. In-vivo Magnetic Resonance Imaging of GABA and Glutamate. 2020."},{"key":"1672_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroimage.2017.07.021","volume":"159","author":"M Mikkelsen","year":"2017","unstructured":"Mikkelsen M, Barker PB, Bhattacharyya PK, Brix MK, Buur PF, Cecil KM, et al. Big GABA: edited MR spectroscopy at 24 research sites. NeuroImage. 2017;159:32\u201345.","journal-title":"NeuroImage"},{"issue":"1","key":"1672_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","volume":"39","author":"CD Rae","year":"2014","unstructured":"Rae CD. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res. 2014;39(1):1\u201336.","journal-title":"Neurochem Res"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01672-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T20:07:30Z","timestamp":1736798850000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01672-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01672-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of Shantou University Medical College (Approval ID: SUMC2022-597) and conducted in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed with the publication of the manuscript in its current form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}